134 related articles for article (PubMed ID: 30024926)
21. Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection.
Sacramento L; Trevelin SC; Nascimento MS; Lima-Jùnior DS; Costa DL; Almeida RP; Cunha FQ; Silva JS; Carregaro V
Infect Immun; 2015 Dec; 83(12):4604-16. PubMed ID: 26371124
[TBL] [Abstract][Full Text] [Related]
22. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
23. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
24. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
Huang X; Barrett RP; McClellan SA; Hazlett LD
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
[TBL] [Abstract][Full Text] [Related]
25. IRAP
Babdor J; Descamps D; Adiko AC; Tohmé M; Maschalidi S; Evnouchidou I; Vasconcellos LR; De Luca M; Mauvais FX; Garfa-Traore M; Brinkmann MM; Chignard M; Manoury B; Saveanu L
Nat Immunol; 2017 May; 18(5):509-518. PubMed ID: 28319098
[TBL] [Abstract][Full Text] [Related]
26. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
Suwarti S; Yamazaki T; Svetlana C; Hanagata N
Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
[TBL] [Abstract][Full Text] [Related]
27. Cross talk between Leishmania donovani CpG DNA and Toll-like receptor 9: an immunoinformatics approach.
Gupta CL; Akhtar S; Waye A; Pandey NR; Pathak N; Bajpai P
Biochem Biophys Res Commun; 2015 Apr; 459(3):424-9. PubMed ID: 25735984
[TBL] [Abstract][Full Text] [Related]
28. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9.
Park B; Brinkmann MM; Spooner E; Lee CC; Kim YM; Ploegh HL
Nat Immunol; 2008 Dec; 9(12):1407-14. PubMed ID: 18931679
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guérin by Flt3-ligand generated dendritic cells.
von Meyenn F; Schaefer M; Weighardt H; Bauer S; Kirschning CJ; Wagner H; Sparwasser T
Immunobiology; 2006; 211(6-8):557-65. PubMed ID: 16920494
[TBL] [Abstract][Full Text] [Related]
30. Cutting edge: a TLR9 cytoplasmic tyrosine motif is selectively required for proinflammatory cytokine production.
Chockalingam A; Rose WA; Hasan M; Ju CH; Leifer CA
J Immunol; 2012 Jan; 188(2):527-30. PubMed ID: 22174451
[TBL] [Abstract][Full Text] [Related]
31. Cell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP mice.
Avalos AM; Kirak O; Oelkers JM; Pils MC; Kim YM; Ottinger M; Jaenisch R; Ploegh HL; Brinkmann MM
J Immunol; 2013 Jan; 190(2):695-702. PubMed ID: 23241879
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 2 suppresses Toll-like receptor 9 responses in Peyer's patch dendritic cells.
Kotaki R; Wajima S; Shiokawa A; Hachimura S
Immunobiology; 2015 Jun; 220(6):734-43. PubMed ID: 25638261
[TBL] [Abstract][Full Text] [Related]
33. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation.
Peter ME; Kubarenko AV; Weber AN; Dalpke AH
J Immunol; 2009 Jun; 182(12):7690-7. PubMed ID: 19494293
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase.
Amcheslavsky A; Bar-Shavit Z
J Bone Miner Res; 2007 Aug; 22(8):1301-10. PubMed ID: 17488193
[TBL] [Abstract][Full Text] [Related]
35. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9.
Knuefermann P; Schwederski M; Velten M; Krings P; Ehrentraut H; Rüdiger M; Boehm O; Fink K; Dreiner U; Grohé C; Hoeft A; Baumgarten G; Koch A; Zacharowski K; Meyer R
Cardiovasc Res; 2008 Apr; 78(1):26-35. PubMed ID: 18194990
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway.
Lin YC; Huang DY; Chu CL; Lin WW
Mol Immunol; 2010 Apr; 47(7-8):1569-78. PubMed ID: 20138367
[TBL] [Abstract][Full Text] [Related]
37. The role of toll-like receptor 9 in chronic stress-induced apoptosis in macrophage.
Xiang Y; Yan H; Zhou J; Zhang Q; Hanley G; Caudle Y; LeSage G; Zhang X; Yin D
PLoS One; 2015; 10(4):e0123447. PubMed ID: 25885582
[TBL] [Abstract][Full Text] [Related]
38. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Derkow K; Krüger C; Dembny P; Lehnardt S
PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
[TBL] [Abstract][Full Text] [Related]
39. Free cholesterol accumulation in liver sinusoidal endothelial cells exacerbates acetaminophen hepatotoxicity via TLR9 signaling.
Teratani T; Tomita K; Suzuki T; Furuhashi H; Irie R; Hida S; Okada Y; Kurihara C; Ebinuma H; Nakamoto N; Saito H; Hibi T; Miura S; Hokari R; Kanai T
J Hepatol; 2017 Oct; 67(4):780-790. PubMed ID: 28554874
[TBL] [Abstract][Full Text] [Related]
40. Granulin is a soluble cofactor for toll-like receptor 9 signaling.
Park B; Buti L; Lee S; Matsuwaki T; Spooner E; Brinkmann MM; Nishihara M; Ploegh HL
Immunity; 2011 Apr; 34(4):505-13. PubMed ID: 21497117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
